Literature DB >> 16314658

Circulating MYCN DNA predicts MYCN-amplification in neuroblastoma.

Valérie Combaret, Christophe Bergeron, Rosa Noguera, Isabelle Iacono, Alain Puisieux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16314658     DOI： 10.1200/JCO.2005.04.0170

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

Review 1.  Liquid biopsy: monitoring cancer-genetics in the blood.

Authors:  Emily Crowley; Federica Di Nicolantonio; Fotios Loupakis; Alberto Bardelli
Journal:  Nat Rev Clin Oncol       Date:  2013-07-09       Impact factor: 66.675

2.  Bone marrow minimal residual disease was an early response marker and a consistent independent predictor of survival after anti-GD2 immunotherapy.

Authors:  Nai-Kong V Cheung; Irina Ostrovnaya; Deborah Kuk; Irene Y Cheung
Journal:  J Clin Oncol       Date:  2015-01-05       Impact factor: 44.544

3.  Circulating Cell-Free DNA Assessment in Biofluids from Children with Neuroblastoma Demonstrates Feasibility and Potential for Minimally Invasive Molecular Diagnostics.

Authors:  Marco Lodrini; Jasmin Wünschel; Theresa M Thole-Kliesch; Maddalena Grimaldi; Annika Sprüssel; Rasmus B Linke; Jan F Hollander; Daniela Tiburtius; Annette Künkele; Johannes H Schulte; Erwin Lankes; Thomas Elgeti; Patrick Hundsdörfer; Kathy Astrahantseff; Thorsten Simon; Angelika Eggert; Hedwig E Deubzer
Journal:  Cancers (Basel)       Date:  2022-04-21       Impact factor: 6.575

4.  Influence of neuroblastoma stage on serum-based detection of MYCN amplification.

Authors:  Valerie Combaret; Michael D Hogarty; Wendy B London; Patrick McGrady; Isabelle Iacono; Stephanie Brejon; Katrien Swerts; Rosa Noguera; Nicole Gross; Raphael Rousseau; Alain Puisieux
Journal:  Pediatr Blood Cancer       Date:  2009-09       Impact factor: 3.167

5.  Detection of tumor ALK status in neuroblastoma patients using peripheral blood.

Authors:  Valérie Combaret; Isabelle Iacono; Angela Bellini; Stéphanie Bréjon; Virginie Bernard; Aurélien Marabelle; Carole Coze; Gaelle Pierron; Eve Lapouble; Gudrun Schleiermacher; Jean Yves Blay
Journal:  Cancer Med       Date:  2015-02-04       Impact factor: 4.452

Review 6.  Opportunities and challenges of circulating biomarkers in neuroblastoma.

Authors:  Ricky M Trigg; Jacqui A Shaw; Suzanne D Turner
Journal:  Open Biol       Date:  2019-05-31       Impact factor: 6.411

7.  Suprarenal Masses in Very Young Infants: Is It Safe to Watch and Wait? Report of a SIOPEN Observational Study Results.

Authors:  Vassilios Papadakis; Vanessa Segura; Massimo Conte; Dominique Plantaz; Andrea Di Cataldo; Gudrun Schleiermacher; Kate Wheeler; Jose D Bermúdez; Shifra Ash; Bénédicte Brichard; Ruth Ladenstein; Valérie Combaret; Sabine Sarnacki; Anna Maria Fagnani; Claudio Granata; Adela Cañete
Journal:  Cancers (Basel)       Date:  2022-08-19       Impact factor: 6.575

8.  Hypermethylated RASSF1A as Circulating Tumor DNA Marker for Disease Monitoring in Neuroblastoma.

Authors:  Lieke M J van Zogchel; Esther M van Wezel; Jalenka van Wijk; Janine Stutterheim; Wassilis S C Bruins; Lily Zappeij-Kannegieter; Tirza J E Slager; Roswitha Schumacher-Kuckelkorn; Iedan R N Verly; C Ellen van der Schoot; Godelieve A M Tytgat
Journal:  JCO Precis Oncol       Date:  2020-04-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.